Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / W••••••••• P••••••••• C•••• Y•••• P••••••• s••••••• A•••• C•••••• P•••••••

Y•••• Invests in W••••••••• P••••••••• C•••• Y•••• P••••••• s••••••• A•••• C•••••• P••••••• and Sentinel Capital Partners in the acquisition of W••••••••• P•••••••••…

Platform acquisitionannouncedannounced Nov 4, 2011Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
FL, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • B••• D••••Deal partnerconfirmed
    Y•••• is excited to partner once again with A•••• and Sentinel, and we know that they will provide a unique balance of strategic and operational excellence to drive a successful investment strategy,” said B••• D••••, a Managing Partner at Y••••.
  • Y•••• Partners is a mezzanine finance firm dedicated to serving middle market private equity sponsored business transactions with a typical investment range of $10 to $40 million in the U.S. and Canada.
Side not stated
Evidence
Y•••• Invests in W••••••••• P••••••••• C•••• Y•••• P••••••• s••••••• A•••• C•••••• P••••••• and Sentinel Capital Partners in the acquisition of W••••••••• P•••••••••…
Y•••• Invests in W••••••••• P••••••••• C•••• Y•••• P••••••• s••••••• A•••• C•••••• P•••••• | Private Equity Intelligence | DFX